Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...
Tag: AstraZeneca
European drugmakers including AstraZeneca pony up for U.S.-listed biopharmas
European drugmakers on Monday announced a trio of deals around a billion dollars each to buy U.S.-listed biopharmas at hefty premiums. Anglo-Swedish AstraZeneca AZN, +1.42% AZN, -1.26% said it’s pay...
EMEA Earnings to Watch: Ryanair, Bayer, AstraZeneca, Richemont
(Bloomberg) — A glance at the Stoxx Europe 600 Index’s performance at the sector level gives an indication of the winners and losers of the third-quarter earnings cycle, with travel and leisure ...
U.S. Cancer Moonshot Needs Stronger Int’l Effort To Make Substantial Progress – Kevin Rudd
Kevin Rudd, president of the Asia Society, introduces Antony Blinken, U.S. Secretary of State, at … [+] George Washington University in Washington, D.C. on May 26, 2022. Photographer: Eric Lee/B...
Singapore Pharmacy Platform Startup Lands $27 Million In Bill Gates-Backed Funding Round
Based in Singapore, SwipeRx enables pharmacists across Southeast Asia to buy medicine through the … [+] platform’s B2B commerce tool. SwipeRx Pharmacy app SwipeRx raised $27 million in a Series ...
AstraZeneca CEO: ‘each of our businesses grew a lot in Q1’
AstraZeneca plc (LON: AZN) on Friday said vaccine contracts helped its Q1 financial results. Moving forward, however, it expects COVID-related sales to sink by 21% to 25%. The stock is nearly flat tod...
Cramer’s lightning round: AstraZeneca is a pass
Intuitive Surgical Inc: “ISRG is one of those stocks – you must not look at it on a day-to-day basis. You look at it on a year-to-year basis, that’s how good their machines are.” Ban...
In the big pharma sector, the best buy is AstraZeneca at prices below $56
GlaxoSmithKline PLC (LON:GSK), Johnson & Johnson (FRA:JNJ), and AstraZeneca PLC (LON:AZN) are certainly the best in the big pharma industry. As the companies compete in the drug wars, investors on...
AstraZeneca reports promising results for its breast cancer therapy
AstraZeneca plc (LON: AZN) closed up roughly 4.0% on Monday after the pharmaceutical behemoth said its cancer drug, Enhertu, showed promising results against a type of breast cancer with poor treatmen...
AstraZeneca reports Q4 results: ‘we’re facing challenges in China’
Shares of AstraZeneca plc (NASDAQ: AZN) are up 3.5% this morning on a significant YoY increase in Q4 revenue. Charges related to the Alexion acquisition, however, pushed it into a quarterly loss. Astr...